Media Pack
News

Current Edition

JCS Volume 15 Issue 4
 
Europe

PCI Clinical Services Announces New Facility Dedicated to Clinical Trial Returns

Continued investment at Bridgend site enables capacity expansion for segregated space in support of the Return of investigational drug products used in Clinical studi...
22 October 2018 Europe | news | Regional News
Continue Reading →
news

PCI Pharma Services Completes Acquisition of Sherpa Clinical Packaging

PCI continues expansion of its global clinical services network to California. Philadelphia, USA – October 2, 2018 Leading global biopharmaceutical outsourcing servic...
22 October 2018 news | North America | Regional News
Continue Reading →
news

New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies

A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even be...
18 October 2018 news | North America | Regional News
Continue Reading →
news

Patients once thought incurable can benefit from high-dose radiation therapy

In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggressive form of high-precision radiation therapy can greatly increase ...
18 October 2018 news | North America | Regional News
Continue Reading →
Asia Pacific

Yisheng receives approval for rabies vaccine clinical study

The PIKA rabies vaccine has completed Phase I and Phase II clinical studies in Singapore.   Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on...
18 October 2018 Asia Pacific | news | Regional News
Continue Reading →
Europe

NHS High Throughput Clinical Research Centres Could Bring Substantial Benefits for Patients

New whitepaper details the potential of High Throughput Centres to make U.K. country of choice for clinical research. Maidenhead, United Kingdom, 8 October 2018 – A n...
18 October 2018 Europe | news | Regional News
Continue Reading →
Asia Pacific

Fiasp is effective at controlling blood sugar levels in children and adolescents living with type 1 diabetes, when compared to conventional insulin aspart

Hyderabad, India, 12 October 2018 ­- For children and adolescents (1 to <18 years old) living with type 1 diabetes, Fiasp® (an ultra-fast acting formulation of ins...
18 October 2018 Asia Pacific | news | Regional News
Continue Reading →
news

Dupixent® (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps

Dupixent significantly reduced nasal polyp size, nasal congestion severity, and need for systemic corticosteroids and/or surgery Dupixent has now demonstrated ...
18 October 2018 news | North America | Regional News
Continue Reading →
Asia Pacific

Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis

Servier, an independent international pharmaceutical company, and the company Galapagos NV announce the start of a global Phase 2 trial with S201086/GLPG1972 in knee...
3 October 2018 Asia Pacific | Europe | Latin America | news | North America | Regional News
Continue Reading →
Europe

Study using DFMO shows positive results for children with high risk neuroblastoma

A paper published September 27 in Scientific Reports shows the positive results of a phase II clinical trial using the oral medication DFMO to prevent relapse in chil...
3 October 2018 Europe | news | Regional News
Continue Reading →
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte